PSNPrescribable
HYDROcodone bitartrate 20 MG 24HR Extended Release Oral Tablet, Abuse-Deterrent
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Hysingla Er Tablet, Extended Release
RxNorm Crosswalk NDC 59011-271
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Hysingla Er (NDC 59011-271) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 14 unique RxNorm concepts. By anchoring Knoa Pharma Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 20 MG Extended Release Oral Tablet
(RxCUI 1595730)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 20 MG 24HR Extended Release Oral Tablet
(RxCUI 1595736)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 30 MG Extended Release Oral Tablet
(RxCUI 1595740)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 30 MG 24HR Extended Release Oral Tablet
(RxCUI 1595742)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 40 MG Extended Release Oral Tablet
(RxCUI 1595746)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 40 MG 24HR Extended Release Oral Tablet
(RxCUI 1595748)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 60 MG Extended Release Oral Tablet
(RxCUI 1595752)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 60 MG 24HR Extended Release Oral Tablet
(RxCUI 1595754)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 80 MG Extended Release Oral Tablet
(RxCUI 1595758)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 80 MG 24HR Extended Release Oral Tablet
(RxCUI 1595760)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 100 MG Extended Release Oral Tablet
(RxCUI 1595764)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 100 MG 24HR Extended Release Oral Tablet
(RxCUI 1595766)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
Abuse-Deterrent 24 HR hydrocodone bitartrate 120 MG Extended Release Oral Tablet
(RxCUI 1595770)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Hysingla ER 120 MG 24HR Extended Release Oral Tablet
(RxCUI 1595772)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Hysingla Er
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 59011-271 to RxCUI 1595730, 1595736, 1595740, 1595742, 1595746, 1595748, 1595752, 1595754, 1595758, 1595760, 1595764, 1595766, 1595770, 1595772, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
* Please review the full disclaimer at the bottom of this page.
